Shell Asset Management’s Bioventus BVS Stock Holding History
Bought
Maintained
Sold
Other funds holding BVS
EWM
JIC
NCM
RA
KLP
Shell Asset Management's BVS Position: Q3 2025 in Review
Shell Asset Management reduced its Bioventus (BVS) stake by 16% in Q3 2025, selling an estimated $1.77K and leaving 1,294 shares worth $9K. The position accounts for ﹤0.01% of the portfolio, ranked #1118.
Shell Asset Management first reported a position in BVS in Q2 2022 and has held it in 13 quarters since. The position peaked at $93K in Q2 2022. 135 funds tracked by Wall St. Rank hold BVS as of Q3 2025.
- Shell Asset Management held 1,294 shares of Bioventus worth $9K as of Q3 2025.
- Shell Asset Management sold 255 Bioventus shares in Q3 2025, an estimated $1.77K.
- Bioventus made up ﹤0.01% of Shell Asset Management's portfolio in Q3 2025, its #1118 holding.
- Shell Asset Management first reported a position in Bioventus in Q2 2022 and has held it in 13 quarters since.
- Shell Asset Management's Bioventus position peaked at $93K in Q2 2022.
- 135 funds tracked by Wall St. Rank held Bioventus as of Q3 2025.
Based on Shell Asset Management's 13F filing for Q3 2025, filed 7 Nov 2025.